Biomarkers from Bench to Bedside: Tools, Targets, and Translational Insights
Explore how new tools and strategies are advancing biomarker discovery, standardization, and translational research in oncology and beyond.
Leveraging Genomic, Preclinical, and Drug Response Data in the Age of AI
Join Dr. Michael Boice from Certis Oncology for a discussion and demonstration of how artificial intelligence can improve preclinical decision-making in cancer research.
Modeling Angiogenesis in Real Time – A Qualitative, Real-time, In-vitro Tube Formation Assay
Lonza demonstrates the successful development of a tube formation assay using their primary human umbilical vein endothelial cells that can be used to visualize angiogenesis in real-time.
Discovery and Engineering of High-Affinity Soluble T Cell Receptors via a High-Throughput Yeast-Based Platform
Join Dr. Garrett Rappazzo as he presents his team’s research on the discovery and engineering of soluble T cell receptors for peptide-HLA targeting therapeutics.
Considerations in Tissue Acquisition and Characterization for the Development of Long-Term Tumoroid Models
Join experts from Discovery Life Science as they explore cutting-edge 3D tumor models and their potential to accelerate cancer research and development.
Advancing Your Innovation: Navigating the Complexity of Stable Cell Line Development
Join experts from ProteoGenix and Eurofins as they share strategies and solutions to streamline stable cell line development, ensuring high yields, clonal homogeneity, and seamless GMP transitions for biopharmaceutical success.
The Impact of Nutrition on T Cell Fate and Exhaustion
Researchers at the Salk Institute have discovered that a switch from acetate to citrate as a nutritional source significantly influences T cell identity, particularly transforming active effector T cells into exhausted ones in chronic infections like cancer and HIV.
Breakthrough CAR-T Cell Therapy Shows Promise Against Deadly Pediatric Brain Tumors
This article from GEN discusses recent successes in CAR-T cell therapy against solid pediatric tumors.
Arrayed CRISPR screening for phenotypic discovery at the MRC-AstraZeneca-University of Cambridge Joint Functional Genomics Screening Laboratory (FGSL)
The FGSL aims to form collaborations to advance our understanding of development and disease mechanism through functional interrogation of the genome at scale.
Reprogramming the Brain Tumor Microenvironment to Enhance Anti-Tumor Immunity
This Q&A report covers essential topics in reprogramming the brain tumor microenvironment, including macrophage roles, cytokine expression, and approaches to overcoming tumor immunosuppression.
Unraveling Immunotherapy Resistance in Advanced Melanoma: Novel Insights from Longitudinal Spatial Multiomics Studies
Explore immunotherapy resistance in melanoma with Dr. Camelia Quek through advanced spatial multiomics and single-cell analysis insights.
Spatial Biology and the Gastrointestinal Tract: Unveiling Cellular Landscapes and Disease Mechanisms
Discover how spatial biology is reshaping our understanding of the gastrointestinal tract, from cellular diversity to disease mechanisms and treatment insights.
Meeting Ethical & Regulatory Requirements When Using Human Biological Specimens
Join us to learn how to navigate ethical and regulatory requirements for using human biological specimens in research.
Deconstructing the Effects of Dietary Fat on Intestinal Cellular Networks
Join Semir Beyaz, PhD as he discusses the effects of dietary fat on the intestinal epithelium, immune cells, and the gut microbiome.
Reprogramming the Brain Tumor Microenvironment to Enhance Anti-Tumor Immunity
Join us to learn how recent discoveries about the brain tumor microenvironment can drive new therapeutic strategies to overcome tumor immunosuppression.
Challenges and Opportunities for Treatment of Metastatic Breast Cancer
Join Dr. Marsha Rosner as she explores innovative strategies and novel approaches to tackle the challenges of metastatic triple-negative breast cancer, a particularly aggressive form of cancer affecting a diverse group of women.
Illuminating Immunohistochemistry: Right-sizing Your Validation and Regulatory Strategy
Join us for the second installment of our enlightening webinar series with Precision for Medicine, focusing on optimizing immunohistochemistry validation and regulatory strategies.
BioMarin Streamlines Pipeline, Discontinues Preclinical Gene Therapy BMN 293
BioMarin has decided to discontinue its preclinical gene therapy, known as BMN 293, which aims to treat myosin-binding protein C3 (MYBPC3) hypertrophic cardiomyopathy.
Using In Vitro Assays to Model Complex Biology with PhenoVista’s Assay Services
Learn about PhenoVista’s unique service offerings and how expertise in developing complex, in vitro studies to provide actionable and relevant data can help drive drug discovery forward.
New CAR T Cell Therapy Shows Promise in Treating Aggressive Brain Cancers
Researchers at McMaster University recently discovered a signaling pathway -- known as PTP4A-ROBO1 -- that glioblastoma (GBM) cells exploit to invade the brain.
Critical Gatekeepers in Cancer Therapy and Prognosis, the Claudin Protein Family
The Claudin protein family is essential in tight junctions, regulating ion and water flow between cells and maintaining tissue integrity to prevent cancer cell migration.
Hematopoietic Stem Cell Fitness and Function During Sickle Cell Disease
Join Dr. Shannon McKinney-Freeman as she presents research on the relationships between sickle cell disease, hematopoietic stem cells, and risks of clonal hematopoeisis and leukemia.
Bringing Oncology Intelligence to Early Drug Development With AI-Powered Response Predictions
In this webinar, learn how AI technologies can accelerate oncology drug discovery and enhance the success of anti-cancer agents.
A Predictive Tool for Immunotherapy Response in Cancer Treatment
Chemotherapy, radiation, and surgical removal of tumors have long been standard cancer treatments. Identifying patients likely to benefit from these treatments remains a challenge.
Illuminating Immunohistochemistry: From Biomarker to Clinical Trial Assay
Join us for an in-depth exploration of immunohistochemistry (IHC) in the first installment of our comprehensive webinar series with Precision for Medicine.
